Moreover, a core component of P-TEFb was identified as cyclin-dependent kinase-9 (CDK9)—a target in chronic lymphocytic leukaemia and necessary for MYC-mediated transcription regulation [26,27,28]. This evidence concerns the gene CDK9 and B-cell chronic lymphocytic leukemia.